Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients

NCT06832774 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic Disease

Interventions

PROCEDURE: Local treatment
DRUG: Gonadotropin releasing hormone analog (GnRHa) + Novel hormone therapy (abiraterone, apalutamide or rezvilutamide).

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine